MEA Parenteral Nutrition Market Report

MEA Parenteral Nutrition Market Analysis By Type of Nutrition (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals), By Dosage Form, By Region, And Segment Forecasts, 2014 - 2025

Published: May 2017  |  100 Pages  |  Format: PDF  |  Report ID: GVR-1-68038-838-1

Industry Insights 

The Middle East and Africa parenteral nutrition market size was valued at USD 203.6 million in 2016 and is expected to grow at a CAGR of 7.1% over the forecast period. Increasing natality rate, rising number of premature births, risk of malnutrition, and increasing prevalence of chronic disorders such as cancer are the key growth rendering drivers responsible for lucrative growth of the market.

Natality rate indicates the total number of births per 1,000 people and is useful to understand the rise in population of a region. Growth in population increases the burden of healthcare cost and food expenditure for a household as well as the nation. Thus, a higher birth rate is expected to impact nutrition level, thereby acting as a driver for the market.

Saudi Arabia parenteral nutrition market, by type of nutrition, 2014 - 2025 (USD Million)

Saudi Arabia parenteral nutrition market

Most of the premature babies suffer from low weight and undeveloped immunity, which puts them at risk. These formulations diminish the risk of infection and underdevelopment, thus promoting its application. The demand for parenteral nutrition is higher in very low birth weight (VLBW) newborns due to low prospect of enteral nutrition. Use of these formulations in premature infants leads to faster neurological development, improved intrauterine nutrient deposition, and minimized risk of complications, thereby improving their chances for survival. 

Malnutrition is one of the major drivers of the market. According to the UNICEF, malnourishment in the first 1,000 days of an infant’s life may lead to impaired cognitive ability and stunted growth. An infant’s diet must contain a proper balance of starch, minerals, vitamins, amino acids, and lipids. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market growth. 

Increasing prevalence of chronic conditions such as cancer unswervingly impacts the use of parenteral nutrition across the country. Parenteral nutrition helps in administration of vital nutrients that are useful in maintaining strength, energy, and hydration level amongst patients throughout the treatment regime. 

Nutrient Type Insights 

Single dose amino acid solutions held a substantial share in 2016. The increased usage of amino acid solutions can be attributed to increase in influx of regulatory approved solutions. Moreover, newly available amino acid solutions result in lesser adverse effects, thus enhancing care delivery. 

Carbohydrates followed single dose amino acids segment in terms of market share in 2016. In addition, intravenous lipid emulsions are projected to witness lucrative growth over the forecast period. Lipid emulsion parenteral formulation showcase promising results, reducing complications such as skin irritation, thrombophlebitis and pain. 

Dosage Form Insights 

Parenteral nutrition can be supplied in various dosage forms, such as vials, ampoules, glass bottles, and bags. Bags are further sub segmented into multi chambered bags and others. Bags dominated the Middle East parenteral nutrition market with more than 67.0% share in 2016. Bags are easy to handle, lightweight, and cost-efficient. Moreover, bags are also easy to dispose after the administration of nutrient to the patient. 

These bags can be single, dual, or triple-chambered. Although single-chambered bags are abundant in market, vials are anticipated to gain substantial share over the forecast period. Vials are often used for smaller concentration dose and they are used in hospital compounding. Increasing focus on customized treatment is likely to boost the usage of vials.

MEA parenteral nutrition market, by dosage form, 2016 (%)

MEA parenteral nutrition market

Regional Insights 

Saudi Arabia held significant share of around 13.4% in 2016 due to the presence of largest health care network and hospitals. Countries such as Kuwait, Oman, Lebanon, and Jordan are anticipated to gain remunerative share over the forecast period. Supportive government initiatives, increasing number of healthcare settings, rising awareness, and increasing healthcare expenditure are likely to support their growth in the coming eight to nine years. Health system in Qatar has improved in the past decade as a result of significant supportive investments by government. The rate of child mortality has declined over the past couple of decades. 

Qatar spent USD 4.7 billion on healthcare in 2014, which was the highest in the Middle East. Kuwait is anticipated to witness lucrative growth over the forecast period owing to supportive government initiatives for expansion of health resources. Approximately 80% of the investment in healthcare sector of Kuwait is made by the government. Kuwait has one of the most modern healthcare infrastructures in the region with adequate clinics, health centers, & hospitals backed by skilled healthcare staff equipped to provide safe & effective healthcare. 

Competitive Insights 

Key players of this market are B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Hospira Inc.; Qatar Pharma Factory; Pharmaceutical Solutions Industry; Kuwait Saudi Pharmaceutical Industries Co.; Alfa Laboratories; and Well Pharma. These companies are actively involved in improving their current product portfolio of parenteral nutrition to sustain their position in the market. In addition, new drug development and their entry in untapped territories are expected to boost growth. 

For instance, in 2015, B. Braun Melsungen AG invested around USD 1.1 Billion in R&D of new products and expansion of production capacities. For instance, it is constructing a new manufacturing unit in Melsungen for the production of individual nutritional solutions. This investment is expected to help the company increase its goodwill.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

Middle East & Africa

Country scope

Saudi Arabia, Qatar, Kuwait, UAE, Oman, Egypt, Lebanon, Jordan

Report coverage

Revenue, company share, competitive landscape, growth factors, trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the MEA parenteral nutrition market on the basis of type of nutrients, dosage form, and region:

  • Nutrient Type Outlook (Revenue, USD Million; 2014 - 2025)

    • Carbohydrate

    • Parenteral Lipid Emulsions

    • Single Dose Amino Acid Solutions

    • Trace Elements

    • Vitamins and Minerals

  • Dosage Form Outlook (Revenue, USD Million; 2014 - 2025)

    • Vials

    • Ampoules

    • Bottles

    • Bags

      • Multi chambered bags

      • Other bags

  • Regional Outlook (Revenue, USD Million; 2014 - 2025)

    • Middle East and Africa

      • Saudi Arabia

      • Qatar

      • Kuwait

      • UAE

      • Oman

      • Egypt

      • Lebanon

      • Jordan

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA